Aflac Inc. reported fourth‑quarter 2025 results that saw total revenue rise to $4.87 billion, beating consensus estimates of roughly $4.28 billion by about $0.59 billion, or 13.8%. Adjusted earnings per diluted share came in at $1.57, falling short of the $1.70 consensus by $0.13, a 7.7% miss. Net earnings were $1.40 billion, down 27.5% from the $1.90 billion reported in the same quarter a year earlier, largely due to a $537 million drop in investment income and a $25 million current expected credit loss (CECL) charge.
The Japan segment delivered net earned premiums of ¥252.6 billion, a 1.9% decline YoY, but the segment still posted a 15.7% premium growth driven by strong sales of its cancer‑insurance product “Miraito.” In contrast, the U.S. segment grew 4.0% to $1.50 billion in net earned premiums, reflecting continued demand for its supplemental‑insurance offerings and a focus on margin improvement through its buy‑to‑build strategy.
Margin pressure is evident in both regions. U.S. pretax adjusted margin contracted to 17.4% from 19.7% YoY, driven by higher benefits and operating expenses, while Japan’s margin slipped slightly. The lower investment income—$537 million versus $1.0 billion a year earlier—contributed to the EPS miss, and the $25 million CECL charge added further headwinds. These factors explain why earnings fell short of expectations despite a revenue beat.
Aflac continued its disciplined capital deployment, completing an $800 million share‑repurchase program for the quarter and announcing a $0.61 dividend for Q1 2026, extending its 43‑year dividend‑aristocrat streak. CEO Daniel Amos highlighted the robust performance of the Japan business and the company’s focus on U.S. margin improvement, while CFO Max Brodén noted the investment portfolio’s resilience and the firm’s flexibility in capital allocation.
The company reiterated its 2026 guidance, projecting a modest decline in Japan earned premiums (1–2%) and U.S. growth at the lower end of the 3–6% range. This guidance signals confidence in core markets while acknowledging macro‑economic uncertainty. After the release, the market reacted with a 1.5% after‑hours decline, reflecting investor focus on the EPS miss.
Overall, Aflac’s results illustrate a mixed picture: revenue growth and strong Japan sales demonstrate demand resilience, but margin compression and lower investment income highlight ongoing headwinds. The company’s continued share buybacks and dividend policy reinforce its commitment to shareholder returns, while the guidance suggests a cautious but steady outlook for the next fiscal year.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.